EPHX2 and diabetic kidney disease: It has been reported that sEH inhibition could protect against acute kidney injury, diabetic nephropathy, lupus nephritis, hypertensive renal damage, tubular epithelial–mesenchymal transition, and renal fibrosis [7,8,11,12,13,14,15].